Gut microbiota predicts the diagnosis of ulcerative colitis in Saudi children

Mohammad El Mouzan1, Ahmed Al Sarkhy2, Asaad Assiri2

  • 1Department of Pediatrics, Gastroenterology Unit, King Saud University, Riyadh 11461, Saudi Arabia. melmouzan@ksu.edu.sa.

Insights

Gut microbiota analysis accurately predicts ulcerative colitis (UC) in children. Specific bacterial and viral biomarkers show high diagnostic potential for UC, suggesting novel therapeutic avenues.

Area of Science:

  • Gastroenterology
  • Microbiome Research
  • Pediatric Inflammatory Bowel Disease

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory disease with unknown etiology, though the gut microbiota's role is increasingly recognized.
  • Understanding the gut microbiome is crucial for diagnosing and potentially treating UC, especially in pediatric populations.

Purpose of the Study:

  • To assess the predictive capability of gut microbiota for diagnosing UC in treatment-naïve Saudi children.
  • To identify specific bacterial and bacteriophage biomarkers for UC diagnosis.

Main Methods:

  • Shotgun metagenomic sequencing of fecal DNA from 20 children with UC and 20 healthy controls.
  • Bioinformatic analysis to identify microbial dysbiosis, including alpha and beta diversity and taxa abundance differences.
  • Receiver operating characteristic (ROC) curve analysis to determine the diagnostic accuracy (Area Under the Curve - AUC) of bacterial and bacteriophage species.

Main Results:

  • High diagnostic accuracy was achieved using microbiota profiles: 89.5% AUC for all bacterial species, increasing to 97.6% with key biomarkers.
  • Bacteriophage analysis also showed high accuracy: 87.4% AUC for all species, rising to 94.5% with important biomarkers.
  • Significant differences in microbial diversity and abundance were observed between UC patients and controls.

Conclusions:

  • Fecal bacterial and viral species demonstrate high potential for noninvasive UC diagnosis in children.
  • The identified bacterial and bacteriophage biomarkers, reduced in UC patients, suggest possibilities for preventive and adjuvant microbial therapies.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
173
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.8K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
343
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
449